# A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis of the Lumbar Spine

> **NCT03110523** · PHASE3 · WITHDRAWN · sponsor: **Techfields Pharma Co. Ltd**

## Conditions studied

- Osteoarthritis of the Lumbar Spine
- Pain, Back

## Interventions

- **DRUG:** X0002

## Key facts

- **NCT ID:** NCT03110523
- **Lead sponsor:** Techfields Pharma Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-03-30
- **Primary completion:** 2024-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic business decision
- **Last updated:** 2023-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03110523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03110523, "A Study to Evaluate the Efficacy and Safety of X0002 Spray in Subjects With Osteoarthritis of the Lumbar Spine". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03110523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*